While without a doubt the internet has made it easier to search for jobs-from such general job-seeking sites as Monster.com to more specialized ones such as JournalismJobs.com-it has also, in some cases, made it more difficult for someone to get hired. According to a survey released in April by CareerBuilder, LLC, nearly 2 in 5 companies use social networking sites to research job candidates. And a March survey from Eurocom Worldwide shows that 1 in 5 technology industry executives admit to rejecting an applicant based on his or her social media profile.

An integrated launch plan was just the start for helping to transform a research organization into a commercial entity. A successful commercial launch of an FDA-approved specialty drug included project management support to a cross-functional client team and development of a dashboard tool to track each function’s progress.

Collaborative helped a research company transitioning to commercialization identify critical timelines, tasks, milestones and resources required to bring a new drug to market. As part of the project, leaders were given the information and tools they needed and the business began building the strong foundation necessary for a successful launch.

The biotechnology and pharmaceutical industry is among the most heavily regulated industries in the world, challenged by evolving regulations, complex compliance requirements and close regulatory scrutiny. At the same time, companies must address the market pressures of globalization, the use of predictive data analytics and digital technologies, and the industry’s ongoing consolidation. In this challenging environment, confidence in internal controls is crucial.

Today’s biotechnology and military companies have high expectations for software performance of electromechanical devices. However, attempting to satisfy all customer demands and features at the outset can lead to costly challenges and inefficiencies down the road. This white paper explains five benefits of taking a phased approach to the development, as well as what to look for when vetting potential contract manufacturing partners.

Today’s biotechnology and military companies have high expectations for software performance of electromechanical devices. However, attempting to satisfy all customer demands and features at the outset can lead to costly challenges and inefficiencies down the road. This white paper explains five benefits of taking a phased approach to the development, as well as what to look for when vetting potential contract manufacturing partners.

In this webinar, you’ll learn how Reltio and IQVIA provide holistic data management solutions for traditional pharma, as well as for emerging biotech and consumer health companies, on Amazon Web Services (AWS).

In this 18-page Scientific Computing eBook, Bennett Lass Ph.D. PMP shares best practices based on his experiences planning and managing ELN deployments in large and small pharmaceutical and biotechnology research organizations.